English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 17 Help

Selected(0)Clear Items/Page:    Sort:
Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells Journal article
Biochemical Pharmacology, 2022,Volume: 197
Authors:  Chen, Yu Chi;  He, Xin Ling;  Qi, Lu;  Shi, Wei;  Yuan, Luo Wei;  Huang, Mu Yang;  Xu, Yu Lian;  Chen, Xiuping;  Gu, Lei;  Zhang, Le Le;  Lu, Jin Jian
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date：2022/03/28
Indoleamine 2, 3-dioxygenase 1  Interferon-γ  Lung Cancer  Myricetin  Programmed Death Ligand-1  
c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2 Journal article
Acta Pharmaceutica Sinica B, 2022,Volume: 12,Issue: 3,Page: 1240-1253
Authors:  Su, Min Xia;  Xu, Yu Lian;  Jiang, Xiao Ming;  Huang, Mu Yang;  Zhang, Le Le;  Yuan, Luo Wei;  Xu, Xiao Huang;  Zhu, Qi;  Gao, Jian Li;  Lu, Jia Hong;  Chen, Xiuping;  Huang, Ming Qing;  Wang, Yitao;  Lu, Jin Jian
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date：2022/04/06
Aggresomes  C-myc  Everolimus  Ginsenoside Rh2  Lung Cancer  P62  Paraptosis  Trib3  
Regulation of CD47 expression by interferon-gamma in cancer cells Journal article
Translational Oncology, 2021,Volume: 14,Issue: 9
Authors:  Ye, Zi Han;  Jiang, Xiao Ming;  Huang, Mu Yang;  Xu, Yu Lian;  Chen, Yu Chi;  Yuan, Luo Wei;  Huang, Can Yu;  Yu, Wei Bang;  Chen, Xiuping;  Lu, Jin Jian
Favorite |  | TC[WOS]:2 TC[Scopus]:3 | Submit date：2021/12/08
Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms Journal article
Pharmacology and Therapeutics, 2021,Volume: 219
Authors:  Huang,Mu Yang;  Jiang,Xiao Ming;  Wang,Bing Lin;  Sun,Yang;  Lu,Jin Jian
Favorite |  | TC[WOS]:17 TC[Scopus]:17 | Submit date：2021/03/02
Challenge  Combination Therapy  Immunotherapy  Mechanism  Nsclc  Pd-1/pd-l1  
Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells Journal article
Phytomedicine, 2021,Volume: 80
Authors:  Yuan,Luo Wei;  Jiang,Xiao Ming;  Xu,Yu Lian;  Huang,Mu Yang;  Chen,Yu Chi;  Yu,Wei Bang;  Su,Min Xia;  Ye,Zi Han;  Chen,Xiuping;  Wang,Yitao;  Lu,Jin Jian
Favorite |  | TC[WOS]:5 TC[Scopus]:7 | Submit date：2021/03/01
Ifn-γ  Licochalcone a  Natural Products  Pd-l1  Protein Synthesis Inhibitor  Ros  
Regulation of CD47 expression in cancer cells Journal article
Translational Oncology, 2020,Volume: 13,Issue: 12
Authors:  Huang,Can Yu;  Ye,Zi Han;  Huang,Mu Yang;  Lu,Jin Jian
Favorite |  | TC[WOS]:10 TC[Scopus]:10 | Submit date：2021/03/02
Cd47  Cytokine  Microrna  Oncogene  Qpctl  
Bioactive platycodins from Platycodonis Radix: Phytochemistry, pharmacological activities, toxicology and pharmacokinetics Journal article
Food Chemistry, 2020,Volume: 327
Authors:  Zhang,Le Le;  Huang,Mu Yang;  Yang,Yong;  Huang,Ming Qing;  Shi,Jia Jie;  Zou,Liang;  Lu,Jin Jian
Favorite |  | TC[WOS]:22 TC[Scopus]:22 | Submit date：2021/03/02
Pharmacokinetics  Pharmacological Activities  Phytochemistry  Platycodins  Platycodonis Radix  Toxicology  
TGFβ2-mediated epithelial–mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance Journal article
Acta Pharmacologica Sinica, 2020,Volume: 42,Issue: 3,Page: 451-459
Authors:  Jiang,Xiao ming;  Xu,Yu lian;  Yuan,Luo wei;  Zhang,Le le;  Huang,Mu yang;  Ye,Zi han;  Su,Min xia;  Chen,Xiu ping;  Zhu,Hong;  Ye,Richard D.;  Lu,Jin jian
Favorite |  | TC[WOS]:7 TC[Scopus]:7 | Submit date：2021/03/01
Egfr Mutant Non-small Cell Lung Cancer  Epithelial-mesenchymal Transition  Nf-κb  Osimertinib Resistance  Tgfβ2  
Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells Journal article
Chinese Journal of Natural Medicines, 2020,Volume: 18,Issue: 7,Page: 517-525
Authors:  CHEN,Yu Chi;  HUANG,Mu Yang;  ZHANG,Le Le;  FENG,Zhe Ling;  JIANG,Xiao Ming;  YUAN,Luo Wei;  HUANG,Run Yue;  LIU,Bo;  YU,Hua;  WANG,Yi Tao;  CHEN,Xiu Ping;  LIN,Li Gen;  LU,Jin Jian
Favorite |  | TC[WOS]:8 TC[Scopus]:8 | Submit date：2021/03/01
C-jun  Jnk  Lung Cancer  Nagilactone e  Programmed Death Ligand 1  
SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts Journal article
Virologica Sinica, 2020,Volume: 35,Issue: 3,Page: 321-329
Authors:  Shu,Ting;  Huang,Muhan;  Wu,Di;  Ren,Yujie;  Zhang,Xueyi;  Han,Yang;  Mu,Jingfang;  Wang,Ruibing;  Qiu,Yang;  Zhang,Ding Yu;  Zhou,Xi
Favorite |  | TC[WOS]:66 TC[Scopus]:74 | Submit date：2021/03/02
Antiviral Target  Helicase  Nsp13  Ntpase  Sars-coronavirus-2 (Sars-cov-2)